Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation

This publication has 54 references indexed in Scilit:

• Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2002
• CB2 cannabinoid receptor-mediated peripheral antinociception
  Published by Wolters Kluwer Health ,2001
• Activation of spinal cannabinoid ₁ receptors inhibits C‐fibre driven hyperexcitable neuronal responses and increases [³⁵S]GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats
  European Journal of Neuroscience, 2000
• The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
  FEBS Letters, 1995
• Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2
  Life Sciences, 1995
• Molecular characterization of a peripheral receptor for cannabinoids
  Nature, 1993
• Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia
  Pain, 1990
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA
  Nature, 1990
• Ethical guidelines for investigations of experimental pain in conscious animals
  PAIN®, 1983
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981